Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Wohlkönig Christoph |
** = Publikationen gelistet in SCI/SSCI/Pubmed
2023
Originalarbeit (Zeitschrift)
** Barth, DA; Moik, F; Steinlechner, S; Posch, F; Mayer, MC; Sandner, AM; Berton, F; Schlintl, V; Koch, L; John, N; Wurm, R; Pichler, M; Bauernhofer, T; Reimann, P; Wohlkönig, C; Richtig, E; Winder, T; Preusser, M; Jost, PJ; Ay, C; Gerger, A; Terbuch, A; Riedl, JM
Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort study.
J Immunother Cancer. 2023; 11(12):
Doi: 10.1136/jitc-2023-007765
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Barth, D; Moik, F; Steinlechner, SM; Posch, F; Schlintl, V; Koch, L; John, N; Wurm, R; Pichler, M; Bauernhofer, T; Reimann, P; Wohlkönig, C; Richtig, E; Winder, T; Preusser, M; Jost, PJ; Ay, C; Gerger, A; Terbuch, A; Riedl, JM
Early kinetics of C-reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: A multi-center cohort study
ANN ONCOL. 2023; 34: S259-S259.-Annual Meeting of the European-Society-for-Medical-Oncology (ESMO); OCT 20-24, 2023; Barcelona, SPAIN.
Doi: 10.1016/j.annonc.2023.09.2917
[Poster]
Web of Science
FullText
FullText_MUG
2022
Abstract (Zeitschrift)
** Riedl, JM; Barth, D; Steinlechner, S; Moik, F; Posch, F; Schlintl, V; Mayer, MC; Sandner, AM; Berton, F; Koch, L; John, N; Wurm, R; Pichler, M; Absenger, G; Jost, PJ; Wohlkonig, C; Richtig, E; Winder, T; Gerger, A; Terbuch, A
Early CRP Kinetics after Initiation of Immune Checkpoint Inhibitors is a predictive Biomarker for Treatment Response independent of the Tumor Antity
ONCOL RES TREAT. 2022; 45(SUPPL 2):228-228.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; Okt 7-10, 2022; Wien.
[Poster]
Web of Science
2021
Abstract (Zeitschrift)
** Terbuch, A; Absenger, G; Steinlechner, S; Jost, P; Wurm, R; Wohlkonig, C; Olschewski, H; Richtig, E; Koch, L; Winder, T; Woll, E; Gerger, A
Autriche - AUsTrian Registry for Immune CHEckpoint inhibitors
ONCOL RES TREAT. 2021; 44: 229-229.
[Poster]
Web of Science
2018
Originalarbeit (Zeitschrift)
** Frille, A; Leithner, K; Olschewski, A; Olschewski, H; Wohlkönig, C; Hrzenjak, A
No erythropoietin-induced growth is observed in non-small cell lung cancer cells.
Int J Oncol. 2018; 52(2): 518-526.
Doi: 10.3892/ijo.2017.4225
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2017
Originalarbeit (Zeitschrift)
** Troester, N; Palfner, M; Dominco, M; Wohlkoenig, C; Schmidberger, E; Trinker, M; Avian, A
Positional therapy in sleep apnoea - one fits all? What determines success in positional therapy in sleep apnoea syndrome.
PLoS One. 2017; 12(4):e0174468-e0174468
Doi: 10.1371/journal.pone.0174468
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wohlkoenig, C; Leithner, K; Olschewski, A; Olschewski, H; Hrzenjak, A
TR3 is involved in hypoxia-induced apoptosis resistance in lung cancer cells downstream of HIF-1α.
Lung Cancer. 2017; 111(3):15-22
Doi: 10.1016/j.lungcan.2017.06.013
Web of Science
PubMed
FullText
FullText_MUG
2016
Abstract (Zeitschrift)
** Pfeiffer, S; Polachova, J; Wohlkoenig, C; Olschewski, H
Immunotherapy against Biomarkers
WIEN KLIN WOCHENSCHR. .. 2016; 128(19-20):756-756.
[Poster]
Web of Science
2015
Originalarbeit (Zeitschrift)
** Fischer, C; Leithner, K; Wohlkoenig, C; Quehenberger, F; Bertsch, A; Olschewski, A; Olschewski, H; Hrzenjak, A
Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization.
Mol Cancer. 2015; 14(8):4-4
Doi: 10.1186/1476-4598-14-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Leithner, K; Hrzenjak, A; Trötzmüller, M; Moustafa, T; Köfeler, HC; Wohlkoenig, C; Stacher, E; Lindenmann, J; Harris, AL; Olschewski, A; Olschewski, H
PCK2 activation mediates an adaptive response to glucose depletion in lung cancer.
Oncogene. 2015; 34(8):1044-1050
Doi: 10.1038/onc.2014.47
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Fischer, C; Leithner, K; Wohlkoenig, C; Quehenberger, F; Bertsch, A; Olschewski, A; Olschewski, H; Hrzenjak, A
Histone deacetylase inhibitor panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma via HIF-1α destabilisation
Wiener Klinische Wochenschrift. 2015; 127: 816-817.-Annual Meeting of the Austrian Society of Pneumology; Oct 15-17, 2015; Graz, Austria.
[Poster]
Web of Science
2014
Originalarbeit (Zeitschrift)
** Leithner, K; Wohlkoenig, C; Stacher, E; Lindenmann, J; Hofmann, NA; Gallé, B; Guelly, C; Quehenberger, F; Stiegler, P; Smolle-Jüttner, FM; Philipsen, S; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H
Hypoxia increases membrane metallo-endopeptidase expression in a novel lung cancer ex vivo model - role of tumor stroma cells.
BMC Cancer. 2014; 14(1):40-40
Doi: 10.1186/1471-2407-14-40
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Hrzenjak, A; Fischer, C; Leithner, K; Wohlkoenig, C; Quehenberger, F; Olschewski, A; Olschewski, H
Panobinostat reduces hypoxia-related cisplatin resistance of non-small cell lung carcinoma cells via HIF-1alpha destabilization.
EUR J CANCER. 2014; 50: S203-S204.
Doi: 10.1016/S0959-8049(14)50741-1
[Poster]
Web of Science
FullText
FullText_MUG
** Leithner, K; Hrzenjak, A; Trotzmuller, M; Moustafa, T; Kofeler, HC; Wohlkoenig, C; Stacher, E; Harris, AL; Olschewski, A; Olschewski, H;
Role of the gluconeogenic enzyme phosphoenolpyruvate carboxykinase in lung cancer.
EUR J CANCER. 2014; 50: S84-S84.-EACR 23;
Doi: 10.1016/S0959-8049(14)50315-2
[Poster]
Web of Science
FullText
FullText_MUG
2013
Abstract (Zeitschrift)
** Wohlkonig, C; Leithner, K; Hrzenjak, A; Olschewski, A; Olschewski, H;
Cytosporone B, an nr4a1 specific cytotoxic agent, is not prone to hypoxia-induced apoptosis resistance in A549 cells.
WIEN KLIN WOCHENSCHR. 2013; 125(19-20):663-663.-ÖGP; OKT 24-26, 2013; Vienna, AUSTRIA.
[Poster]
Web of Science
2012
Originalarbeit (Zeitschrift)
** Li, Y; Connolly, M; Nagaraj, C; Tang, B; Bálint, Z; Popper, H; Smolle-Juettner, FM; Lindenmann, J; Kwapiszewska, G; Aaronson, PI; Wohlkoenig, C; Leithner, K; Olschewski, H; Olschewski, A
Peroxisome proliferator-activated receptor-β/δ, the acute signaling factor in prostacyclin-induced pulmonary vasodilation.
Am J Respir Cell Mol Biol. 2012; 46(3):372-379
Doi: 10.1165/rcmb.2010-0428OC
Web of Science
PubMed
FullText
FullText_MUG
2011
Originalarbeit (Zeitschrift)
** Wohlkoenig, C; Leithner, K; Deutsch, A; Hrzenjak, A; Olschewski, A; Olschewski, H
Hypoxia-induced cisplatin resistance is reversible and growth rate independent in lung cancer cells.
Cancer Lett. 2011; 308(2): 134-143.
Doi: 10.1016/j.canlet.2011.03.014
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Leithner, K; Wohlkoenig, C; Stacher, E; Lindenmann, J; Ebner, B; Guelly, C; Smolle-Jüttner, FM; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H
Neprilysin is induced by hypoxia and is a prognostic factor in non-small cell lung cancer
WIEN KLIN WOCHENSCHR. 2011; 123(17-18):A24-A24.-Jahrestagung der Österreichischen Gesellschaft für Pneumologie; SEPT 8-10, 2011; Vienna, AUSTRIA.
[Oral Communication]
Web of Science
** Wohlkoenig, C; Leithner, K; Hrzenjak, A; Olschewski, A; Olschewski, H
Down-regulation of the pro-apoptotic BCL-2 family member protein Bax by hypoxia may contribute to hypoxia-induced chemotherapy resistance in A549 lung cancer cells
WIEN KLIN WOCHENSCHR. 2011; 123(17-18):A33-A33.-Jahrestagung der Österreichischen Gesellschaft für Pneumologie; SEPT 8-10, 2011; Vienna, AUSTRIA.
[Oral Communication]
Web of Science
** Wohlkonig, C; Meilinger, M; Flick, H; Fritz, W; Hesse, C; Wurm, R; Polachova, J; Krause, R; Popper, H; Olschewski, H
Necrotizing epithelioid granulomatous infiltrates - mycobacterium infection, what else?
WIEN KLIN WOCHENSCHR. 2011; 123(17-18):A11-A11.
[Poster]
Web of Science
2010
Abstract (Zeitschrift)
** Frille, A; Wohlkoenig, C; Leithner, K; Hrzenjak, A; Olschewski, A; Olschewski, H.
The influence of erythropoietin on proliferation in lung cancer cell lines
Wiener Klinische Wochenschrift2010; 122(21-2):A51--Jahrestagung 2010 der Österreichischen Gesellschaft für Pneumologie; OKT 7-9, 2010; Graz, AUSTRIA.
[Poster]
Web of Science
** Leithner, K; Wohlkoenig, C; Li, Y; Tang, B; Nagaraj, C; Stacher, E; Balint, Z; Olschewski, A; Olschewski, H
Expression of TASK-1 and TASK-3 channels in non-small cell lung cancer
EJC SUPPL. 2010; 8(5): 576
Doi: 10.1016/S1359-6349(10)71377-X
[Poster]
Web of Science
FullText
FullText_MUG
** Leithner, K; Wohlkoenig, C; Stacher, E; Lindenmann, J; Smolle-Juttner, F; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H
Constitutive expression of carbonic anhydrase IX in hypoxic and normoxic non-small cell lung cancer fragments
EJC SUPPL. 2010; 8(5): 192
Doi: 10.1016/S1359-6349(10)70999-X
[Poster]
Web of Science
FullText
FullText_MUG
** Leithner, K; Wohlkoenig, C; Stacher, E; Lindenmann, J; Smolle-Juttner, FM; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H
Expression of key enzymes for gluconeogenesis and glycogen deposition in lung cancer
WIEN KLIN WOCHENSCHR. 2010; 122(21-22): A50-A50.
[Poster]
Web of Science
** Wohlkoenig, C; Leithner, K; Hrzenjak, A; Olschewski, A; Olschewski, H
Autocrine vascular endothelial growth factor signaling has no influence on the apoptosis induction by cisplatin in non-small cell lung cancer cell lines
EJC SUPPL. 2010; 8(5): 538
Doi: 10.1016/S1359-6349(10)71339-2
[Poster]
Web of Science
FullText
FullText_MUG
** Wohlkoenig, C; Leithner, K; Hrzenjak, A; Olschewski, A; Olschewski, H
Blocking autocrine secreted vascular endothelial growth factor does not enhance cisplatin-induced apoptosis in non-small cell lung cancer cell lines
Wiener Klinische Wochenschrift
2010; 122(21-2):A53--Jahrestagung 2010 der Österreichischen Gesellschaft für Pneumologie; OKT 7-9, 2010; Graz.
[Oral Communication]
Web of Science
2009
Originalarbeit (Zeitschrift)
** Leithner, K; Stacher, E; Wurm, R; Ploner, F; Quehenberger, F; Wohlkoenig, C; Bálint, Z; Polachova, J; Olschewski, A; Samonigg, H; Popper, HH; Olschewski, H
Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy.
Lung Cancer. 2009; 65(1):98-104
Doi: 10.1016/j.lungcan.2008.10.015
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Abstract (Zeitschrift)
** Leithner, K; Wohlkoenig, C; Stacher, E; Lindenmann, J; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H
Moderate hypoxia induces hypoxic adaptation in an ex-vivo non-small cell lung cancer model
Wiener Klinische Wochenschrift 2009; 121(17-1):A50--ÖGP Annual Congress; JUN 11-13; Salzburg, AUSTRIA.
[Poster]
Web of Science